Skip to main content
Clinical Trials/NCT00856882
NCT00856882CompletedNot Applicable

The Effects of Soy Protein and/or Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors-a Six Months RCT Among Postmenopausal Women

Chinese University of Hong Kong0 sitesStarted: October 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed

Study Overview

Brief Summary

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
46 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes

Exclusion Criteria

  • Women with breast, ovary or other cancers in recent 5-year
  • Severe renal or liver dysfunction
  • Women with androgen excess
  • Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.

Investigators

Sponsor Class
Other

Similar Trials

The Effects of Soy Protein and Isoflavones... | Clinical Trial